Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Behavior of Gas Molecules: Molecular Diffusion, Mean Free Path, and Effusion03:48

Behavior of Gas Molecules: Molecular Diffusion, Mean Free Path, and Effusion

31.2K
Although gaseous molecules travel at tremendous speeds (hundreds of meters per second), they collide with other gaseous molecules and travel in many different directions before reaching the desired target. At room temperature, a gaseous molecule will experience billions of collisions per second. The mean free path is the average distance a molecule travels between collisions. The mean free path increases with decreasing pressure; in general, the mean free path for a gaseous molecule will be...
31.2K
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

4.1K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
4.1K
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

679
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
679
Induced-fit Model01:13

Induced-fit Model

88.9K
Most chemical reactions in cells require enzymes—biological catalysts that speed up the reaction without being consumed or permanently changed. They reduce the activation energy needed to convert the reactants into products. Enzymes are proteins, that usually work by binding to a substrate—a reactant molecule that they act upon.
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
88.9K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

27.3K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.3K
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

2.1K
Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acid-Base Disorders in the Critically Ill Patient.

Clinical journal of the American Society of Nephrology : CJASN·2022
Same author

Partial Fanconi syndrome induced by ifosfamide.

Proceedings (Baylor University. Medical Center)·2019
Same journal

Supporting patient understanding of cervical and ovarian cancer: how well does AI perform?

Proceedings (Baylor University. Medical Center)·2026
Same journal

Nationwide analysis of adult nongonococcal septic knee arthritis hospitalizations from 2016 to 2022.

Proceedings (Baylor University. Medical Center)·2026
Same journal

Ferrier and Horsley in America, 1888: cerebral localization and neurosurgery.

Proceedings (Baylor University. Medical Center)·2026
Same journal

Anesthetic management of a high-risk cesarean delivery in a patient with multivessel Takayasu arteritis.

Proceedings (Baylor University. Medical Center)·2026
Same journal

Diffuse pulmonary meningotheliomatosis in a patient with autoimmune thyroiditis and chronic inflammatory disease.

Proceedings (Baylor University. Medical Center)·2026
Same journal

Color-segmented fluorescence ("red capping") sentinel lymph node biopsy in melanoma: a comparative analysis of node positivity rates with indocyanine green.

Proceedings (Baylor University. Medical Center)·2026
See all related articles

Related Experiment Video

Updated: Jan 21, 2026

A Pleural Effusion Model in Rats by Intratracheal Instillation of Polyacrylate/Nanosilica
03:32

A Pleural Effusion Model in Rats by Intratracheal Instillation of Polyacrylate/Nanosilica

Published on: April 12, 2019

8.3K

Hydralazine-induced pericardial effusion.

Mohammed Faisal Rahman1, Muhammad Ajmal Panezai1, Harold M Szerlip1

  • 1Division of Nephrology, Baylor University Medical CenterDallasTexas.

Proceedings (Baylor University. Medical Center)
|August 7, 2019
PubMed
Summary
This summary is machine-generated.

Drug-induced lupus (DIL) is an autoimmune reaction to medication. This report details a rare case of hydralazine-induced lupus without antinuclear antibodies, highlighting diagnostic challenges.

Keywords:
ANA-negative drug-induced lupushydralazine-induced lupuspericardial effusion

More Related Videos

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.8K
Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
03:22

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion

Published on: November 10, 2023

1.4K

Related Experiment Videos

Last Updated: Jan 21, 2026

A Pleural Effusion Model in Rats by Intratracheal Instillation of Polyacrylate/Nanosilica
03:32

A Pleural Effusion Model in Rats by Intratracheal Instillation of Polyacrylate/Nanosilica

Published on: April 12, 2019

8.3K
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.8K
Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
03:22

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion

Published on: November 10, 2023

1.4K

Area of Science:

  • Rheumatology
  • Clinical Immunology
  • Pharmacology

Background:

  • Drug-induced lupus (DIL) is an autoimmune condition triggered by medications.
  • Hydralazine is a common cause of DIL, typically associated with positive antinuclear antibody (ANA) tests.
  • The incidence of DIL in the US is estimated between 15,000 and 30,000 cases annually.

Observation:

  • This report presents a case of DIL.
  • The patient developed DIL secondary to hydralazine use.
  • The case is notable for being ANA-negative.

Findings:

  • The patient exhibited symptoms consistent with DIL.
  • Diagnostic workup revealed no detectable antinuclear antibodies.
  • This finding challenges the typical presentation of hydralazine-induced lupus.

Implications:

  • ANA-negative DIL is a rare but possible diagnosis.
  • Clinicians should consider DIL even in the absence of ANA.
  • Further research is needed to understand the mechanisms of ANA-negative DIL.